Skip to main content
. 2021 Nov 15;50:116477. doi: 10.1016/j.bmc.2021.116477

Figure 2.

Figure 2

A representation of the X-ray crystallographic analysis of the RmlA-8a complex (blue, [PDB 4ASJ]) overlaid with the analysis of the RmlA-1a complex (yellow, [PDB 5FTV]). A subtle change in the positioning of the N1-benzyl group resulted from the bromine atom being present in the 4-position of inhibitor 1a.